60 Degrees Pharmaceuticals, Inc. (SXTP)
60 Degrees Pharmaceuticals will go public soon. The estimated IPO date is June 1, 2023.
IPO Price Range
$4.30 - $6.30
Shares Offered
1,415,095
Deal Size
$7.50M
Chart not available yet
Data will show when the stock starts trading on Jun 1, 2023.
| Market Cap | 29.52M |
| Revenue (ttm) | 845,174 |
| Net Income (ttm) | -5.62M |
| Shares Out | 5.57M |
| EPS (ttm) | -1.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About SXTP
60 Degrees Pharmaceuticals is a growth-oriented specialty pharmaceutical company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. We have successfully achieved regulatory approval of Arakoda, a malaria preventative treatment that has been on the market since late 2019. Currently, 60P’s pipeline under development covers development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda ... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
60 Degrees Pharmaceuticals IPO Registration Document (S-1)
60 Degrees Pharmaceuticals has filed to go public with an IPO on the NASDAQ.
4 months ago - SEC